4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-014119
Chief Legal Officer sold 6,244 shares at $27.50 ($171,710)
- Chief Legal Officer acquired 6,244 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise 10b5-1 | +1,332 | $6.49 | $8,645 | 3,069 | D |
| Bizily Scott Chief Legal Officer | 2024-02-08 | Sale 10b5-1 | −1,332 | $27.50 | $36,630 | 1,737 | D |
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise 10b5-1 | +2,916 | $8.04 | $23,445 | 4,653 | D |
| Bizily Scott Chief Legal Officer | 2024-02-08 | Sale 10b5-1 | −2,916 | $27.50 | $80,190 | 1,737 | D |
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise 10b5-1 | +1,996 | $15.78 | $31,497 | 3,733 | D |
| Bizily Scott Chief Legal Officer | 2024-02-08 | Sale 10b5-1 | −1,996 | $27.50 | $54,890 | 1,737 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,332 | 17,043 | D | ||
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,916 | 45,834 | D | ||
| Bizily Scott Chief Legal Officer | 2024-02-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,996 | 23,004 | D | ||
| Open-market sales · 6,244 sh · avg $27.50 · $171,710 | |||||||
Loading xslF345X05/ownership.xml…